WO2001009387A1 - Isolation of novel hemapoietic genes by representational difference analysis - Google Patents

Isolation of novel hemapoietic genes by representational difference analysis Download PDF

Info

Publication number
WO2001009387A1
WO2001009387A1 PCT/US2000/020746 US0020746W WO0109387A1 WO 2001009387 A1 WO2001009387 A1 WO 2001009387A1 US 0020746 W US0020746 W US 0020746W WO 0109387 A1 WO0109387 A1 WO 0109387A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
red
blooded
fish
seq
Prior art date
Application number
PCT/US2000/020746
Other languages
French (fr)
Inventor
William H. Detrich, Iii
Donald A. Yergeau
Original Assignee
Northeastern University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northeastern University filed Critical Northeastern University
Publication of WO2001009387A1 publication Critical patent/WO2001009387A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855Ligating adaptors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention encompasses a screening method for discovering novel erythrocytic genes, by PCR-based analysis of representational differences between two species of Antarctic fish, a red-blooded species and a white-blooded, hemoglobin- and erythrocyte-lacking species. The invention also encompasses methods of using PCR-based representational difference analysis to discover myelopoiesis and lymphopoiesis related genes from icefish of the Channicthyidae family of the Notothenioidei suborder. Also disclosed are new clones containing putative genes involved in erythropoiesis.

Description

TITLE OF THE INVENTION
ISOLATION OF NOVEL HEMAPOIETIC GENES BY REPRESENTATIONAL DIFFERENCE ANALYSIS
CROSS REFERENCE TO RELATED APPLICATIONS This application claims the benefit of U.S. provisional application No. 60/146,201, filed July 29, 1999, herein incorporated by reference.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR
DEVELOPMENT
The work leading to the invention was supported at least in part by National Science Foundation Grants OPP- 9420712 and OPP-9815381. Therefore, the U.S. government may have certain rights in the invention.
BACKGROUND OF THE INVENTION Hematopoiesis is the developmental process of blood cell formation and encompasses the production, turnover, and replenishment of all blood cell lineages. Specialized cells, termed "hematopoietic stem cells" (HSCs) , give rise to multiple cell lineages that perform a wide array of functions from infectious defense (lymphocytes and myeloid cells) to transport of molecular oxygen (erythrocytes) . The dominant blood cell type is normally the erythrocyte, which constitutes up to 45% of the total volume of blood. Although intensely studied, red cell development from individual progenitors, termed "erythropoiesis", remains poorly understood.
Red blood cells differentiate from HSCs under the control of lineage-specific factors and of cell-specific gene expression. During erythropoiesis, cytokines such as stem cell ligand (SCL) , interleukin-3 (IL-3), interleukin- 6 (IL-6), and granulocyte-macrophage colony-stimulating factor (GM-CSF) , direct HSCs toward the erythroid/myeloid differentiation program, beginning with development of the BFU-E (blast forming unit-erythroid) (1) . The BFU-Es are activated by the lineage-restricted factor erythropoietin (Epo) to differentiate into colony forming units of erythroid lineage (CFU-E) . Erythropoietin, in synergy with IL-3, is required for commitment and differentiation of CFU-Es and for maintenance of functionally mature erythrocytes 2). Binding of the Epo ligand to its cognate receptor, EpoR, on the CFU-E initiates a signal transduction cascade in which Jak 2 kinase and STAT5 (signal transducer and activator of transcription 5) activate downstream targets such as erythroid-specific transcription factors (e.g., GATA-1, erythroid Kruppel- like factor (EKLF) , etc.) (3;4). Once these downstream targets are activated, proerythroblasts, also termed "colony forming units-erythroid" (CFU-E) , continue to differentiate into mature red blood cells. Structural genes encoding Band 3, Band 4.1, ankyrin and spectrin, are activated to provide the cytoskeletal framework to shape the erythrocyte for movement through the capillary network. Downstream transcription factors (e.g., EKLF) activate production of the oxygen transporter, hemoglobin, and red cell enzymes such as carbonic anhydrase.
The study of blood cell development has been greatly facilitated by the use of model vertebrate genetic systems, in particular the mouse and the zebrafish ( Danio rerio) (5) . The murine system permits functional analysis of hematopoietic genes by means of "gene knock-out" technology (6) . However, this method is biased because it can only provide insight into the functions of genes that have already been discovered. Systematic, large-scale mutagenesis of the zebrafish, on the other hand, has provided a random approach to the discovery of novel hematopoietic genes (7), but the production and screening of mutants and the isolation of mutated genes by positional cloning is a laborious and expensive process. Therefore, there remains a need for a more comprehensive, yet simpler and cost-effective strategy for screening for novel gene products involved in blood cell formation and other processes, including erythropoesis, lymphopoiesis, myelopoiesis, and blood clotting, which need is served by the present invention.
SUMMARY OF THE INVENTION
The inventors have discovered that a unique family of Antarctic fish, the hemoglobin-lacking or "white-blooded" icefish (15 species in the family, Channicthyidae, suborder Notothenioidei) fail to express hemoglobin, due to deletion of most of the juvenile and adult globin gene complexes. Absent hemoglobin, the icefish also no longer produce red blood cells, most likely due to mutations in genes required for erythropoiesis. Interestingly, most other families of the Notothenioid suborder have retained the ability to produce hemoglobin and mature erythrocytes .
Thus, one aspect of the present invention encompasses a method for uncovering unknown hematopoiesis-related genes, particularly erythropoiesis-related genes, by screening for and identifying genes that are expressed by red-blooded animals but not by white-blooded animals. A preferred embodiment screens for genes expressed by red-blooded Notothenioid fish but not white-blooded Notothenioid icefish. The erythropoiesis-related gene screening method employs representational difference analysis (RDA) (12) to clone presumptive erythroid genes that are expressed by red-blooded fish, preferably red-blooded Notothenioids of the Antarctic, such as the rock-cods (used here as the "tester" genome) , but not by white-blooded icefish (used here as the "driver" genome) . When applied to cDNA libraries, this subtractive hybridization methodology enriches for genes expressed solely by the tester genome. That is, the driver cDNA eliminates genes expressed by both genomes to produce a cDNA population enriched for the unique cDNAs of the tester genome . To enrich for red blood cell or erythropoiesis-related cDNA probes, "representations" of total cDNA from the red-cell- forming organ, the head kidney, of the red-blooded Antarctic yellow-belly rock-cod, Notothenia coriiceps (the tester) , were hybridized to total cDNA representations from the head kidney of the white-blooded Antarctic icefish, Chaenocephalus aceratus (the driver) .
Specifically, using polymerase chain reaction (PCR)- based representational difference analysis as a subtractive tool, the inventors obtained 316 partial cDNA clones, or probes. After identification and elimination of cDNA probes corresponding to several known genes (e.g., α- and β-globin) , 179 "background-cleansed" RDA clones remained, whose sequences have been or are being determined. The preliminary sequences of the RDA clones were assembled using the program DNASTAR to yield 45 distinct contigs (i.e., overlapping, contiguous sections of a cDNA, gene, or segment of genome) that are expressed by N. coriiceps but not by the icefish, C. aceratus . The success of the present method for screening for erythropoesis-related genes has been shown by the recovery of many clones encoding the α and β chains of hemoglobin, expressed only by N. coriiceps and not by C. aceratus . The subtraction products obtained also included others of as yet undetermined or "unknown" function. Using the representational difference products as probes for Northern blot analysis and in situ hybridization, the patterns of expression of both known and unknown genes in fish hematopoietic tissues, including blood, head kidney, and spleen, have been characterized. Furthermore, the genomes of red- and white-blooded Notothenioids have been probed for other known erythropoietic genes, using zebrafish (Danio rerio) hematopoietic-specific markers. Genes essential for early, but not late, development of the erythroid lineage are present in the genome of the icefish C. aceratus. Microscopic analysis has helped to identify putative proerythroblasts in the head kidney and spleen of several icefish species. Together, these results suggest that erythrocytes fail to form in icefish due to mutational blockage of the later stages of differentiation. Analysis of the subtraction products (i.e., unique to the Antarctic rock-
cod head kidney, absent in the icefish head kidney) has begun to reveal novel genes, at least some of whose activities appear to be required for terminal differentiation of erythrocytes . Thus, the invention encompasses several novel RDA clones, their corresponding full-length cDNAs, and their cognate genes that appear to have a role in blood cell formation and differentiation, particularly in erythropoesis . The invention encompasses the identification of these gene sequences and their encoded proteins, and the application of these RDA, cDNA, and gene reagents to diagnosis and treatment of erythroid diseases (e.g., sickle cell anemia, clinical anemias resulting from chemotherapy, thalassemias, and the like) . The screening method of the invention is useful for discovering gene products such as erythroid transcription factors, cytokines, cytokine receptors, and signaling enzymes.
Additionally, the invention encompasses methods for discovering genes and gene products relating to lymphopoiesis, myelopoiesis and the like, through cloning of cDNAs from the primarily white blood cell-containing hemapoietic tissues of the erythrocyte-lacking icefish. BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING
Figure 1 shows an overview schematic of the representational difference analysis procedure (RDA) applied to subtract the red-blooded N. coriiceps head kidney cDNA (tester) by hybridization to the white-blooded C. aceratus head kidney cDNA (driver) , according to the method of the invention;
Figure 2 shows a Northern slot blot produced using total RNAs from various tissues of either N. coriiceps (N. c. ) or C. acera tus ( C. a . ) ;
Figure 3 depicts a Northern slot blot analysis of the tissue-specific expression patterns of five representational difference products (RDA15, RDA23, RDA34, RDA263, RDA289); Figure 4 shows the results of in situ hybridization of the α-globin RNA transcripts to blood cells of red- and white-blooded Antarctic fish species;
Figure 5 shows the results of in situ hybridization of RDA15 clone; Figure 6 shows the results of in situ hybridization of the RDA197 clone;
Figure 7 shows the results of in si tu hybridization of the RDA23 clone;
Figure 8 illustrates the morphologies of the cells of spleen tissue prints;
Figure 9 shows a Southern hybridization of the murine erythropoietin receptor cDNA to genomic DNAs of different fish species;
Figure 10 shows a Southern hybridization of zebrafish Band 3 cDNA to genomic DNAs of different fish species; Figure 11 depicts a Southern hybridization of zebrafish α-spectrin cDNA to genomic DNAs of different fish species;
Figure 12A depicts a schematic representation of the cDNA 23-8 clone and its coding region, while Figure 12B is a Northern slot blot showing cDNA 23-8 's hybridization pattern in different organs of N. coriiceps and
C. aceratus;
Figure 13 is a schematic depiction of cDNA clone 23- 10/4 and its coding region;
Figure 14A is a schematic depiction of the coding region of clone 15-17/13, while Figure 14B shows its hybridization pattern in N. coriiceps and C. aceratus;
Figure 15A is a schematic depiction of the cDNA 162- 3 clone and its coding region, and Figure 15B is a Northern slot blot showing its hybridization pattern in different organs of N. coriiceps and C. acera tus; and
Figure 16A is a schematic depiction of the cDNA 295- 5 clone and its coding region, and Figure 16B is a Northern slot blot showing its hybridization pattern in different organs of N. coriiceps and C. aceratus.
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to the discovery of hematopoiesis-related gene by means of representational difference analysis (RDA) to compare the genomes of a red-blooded species and a closely related hemoglobin- lacking, white-blooded species of the same suborder (i.e., one devoid of erythrocytes), thereby subtracting out common DNA sequences and selecting for those uniquely involved in a hematopoiesis pathway of interest. A preferred embodiment exploits a novel, alternative vertebrate model for erythropoietic gene discovery, based on a unique group of Antarctic fish, the hemoglobin- lacking icefish.
The fifteen species of the Antarctic icefish family Channichthyidae, belonging to the suborder Notothenioidei, appear unique among vertebrates in their inability to produce red blood cells (erythrocytes) . Their blood contains normal numbers of white blood cells (lymphoid and myeloid cells) and, hence, is transparent (often referred to as "white" in appearance) , in contrast to the opaque, crimson blood of other closely related Antarctic Notothenioids : e.g., Artedidraconidae (spiny plunderfish) , Ba thydraconidae (dragonfish) ,
Harpagiseiidae (plunderfish) , and Nototheniidae (rock- cods) . Icefish transport oxygen to their tissues solely in physical solution. In the cold (approximately -1.86°C to +1°C) , stable, and oxygen-rich environment experienced by these organisms, reduction of the hematocrit to near zero is likely to have been selectively advantageous because it greatly reduces the energy cost associated with circulation of a highly viscous, corpuscular blood fluid
(8-10). Zhao et al . (11) have shown previously that the icefish fail to synthesize hemoglobin due to deletion of most of the adult globin gene complex from their genomes. The present invention is based on the inventors' hypothesis that the erythroid cell lineage fails to develop in the icefish due to mutations (e.g., deletions, point mutations) that eliminate expression of many of the genes required for red cell development and differentiation. Thus, the genomes of icefish provide a unique molecular reagent for discovery of genes and proteins involved in blood cell formation and development. Examples of potential discoveries include genes that code for erythroid transcription factors, cytokines, cytokine receptors, clotting components, and signaling enzymes.
The invention also encompasses the use of representational difference analysis (RDA) to isolate unknown, red cell-specific genes from a red-blooded, Notothenioid fish species, by subtracting cDNA from its major hematopoietic organ, the head kidney, against cDNA from the head kidney of a white-blooded icefish species. RDA was originally developed to analyze the differences between two complex genomes (12) , and was subsequently modified to detect differential gene expression via cDNA subtraction (13) . In RDA, a "tester" genome that potentially expresses genes of interest is hybridized to an excess of a "driver" genome that is not expected to, or does not, express these genes. In the invention's screening method, the tester DNA is cDNA from the head kidney of the red-blooded Antarctic rock-cod, Notothenia coriiceps, and the driver DNA is head kidney cDNA from the hemoglobin-lacking icefish, Chaenocephalus acera tus . Preliminary experiments have detected some cDNAs encoding novel proteins that, given their observed expression patterns in hematopoietic tissues, are likely to function in erythropoiesis. With respect to erythrocytic gene discovery, the present invention provides for isolation and identification of unique, red-cell specific genes involved in erythropoiesis, by cDNA-based RDA using head kidney cDNAs from N. coriiceps and from C. acera tus as tester and driver, respectively. The screening method is guided in part by the tissue-specific expression patterns of the subtraction products (i.e., cDNA clones unique to the red-blooded fish) , as discerned by Northern slot blot analysis and by in situ hybridization of the subtraction products to blood smears and hematopoietic tissue prints from the two species. Genomic Southern blot analysis using the N coriiceps RDA probes and erythropoietic cDNA probes from other vertebrates, has also provided information about the retention or loss of erythropoietic and other hemapoietic genes in C. acera tus . As a result of these efforts, several full-length cDNAs corresponding to several of the RDA products have been or are being obtained. Finally, the invention provides for determining the erythropoietic function of each protein encoded by every full-length clone found in the blood- forming organ of red-blooded fish but not in that of white-blooded icefish. Specifically, an embodiment of the invention directed to screening for and isolation of unique genes for red blood cell formation, uses polymerase chain reaction (PCR) -based, representational difference analysis (RDA) to subtract cDNAs common to the head kidneys of red- and white-blooded Notothenioid fish. Figure 1 shows an overall schematic of the RDA protocol employed, briefly summarized as follows. Tester DNA was a PCR-amplified and enzymatically digested cDNA representation from N. coriiceps head kidney. Particular adapters were ligated to the tester representation (Step 1-A) prior to subtractive hybridization, which adapters were designed to allow, in a later step, exponential PCR amplification of double-stranded (ds) cDNAs unique to the tester population. The adapters also include known tags or signature sequences (e.g., restriction endonuclease sites) , allowing one to ascertain that it was the tester DNA that was selectively PCR-amplified. Driver DNA was a PCR-amplified and enzymatically digested cDNA representation from C. aceratus head kidney. Subtractive hybridization (Step IB) was performed by mixing the tester DNA with excess driver DNA and subjecting the mixture to appropriate conditions for dissociating or melting the DNA molecules into single strands and then to conditions for re-annealing the DNA molecules (Step 1-B) . The resulting DNA pool includes double-stranded (ds) tester DNA, single-stranded (ss) tester DNA, ds-driver DNA, ss-driver DNA, and hybrid molecules of ss-tester DNA hybridized to ss-driver DNA (i.e., representing DNA sequences common to both tester and driver populations) . The DNA mixture was subjected to conditions for filling in the single-stranded or sticky ends of the double- stranded DNA molecules, and then to PCR amplification. This procedure resulted in the exponential amplification of unique ds-tester cDNA, linear amplification of tester/driver hybrids, and no amplification of ss-DNA, Afterwards, single-stranded DNA species were removed by treatment with Mung Bean nuclease, and the tester-derived double-stranded DNA difference products were amplified by PCR (step 1-D) , prior to digestion with at least one restriction endonuclease . The choice of restriction endonuclease will generally be guided by the particular PCT protocol used. For instance, in Example I below, DPNII, a restriction enzyme whose DNA-binding sequence encompasses four bases (termed "a four base-cutter") was used because it made frequent cuts, thereby producing many fragments of about 400-500 bp in size. Other restriction enzymes can be used (e.g., isoschizomers cutting at the same site as DPNII) , as will be appreciated by one of ordinary skill in the art. Three rounds of this subtraction procedure were performed, producing an enriched "difference product" of DNA fragments roughly 200-500 base pairs (bp) in size. The enriched difference products were then each cloned into a plasmid vector, individual clones were isolated and grown, and their DNA inserts (i.e., fragments resulting from the subtraction) were analyzed to determine their respective sequences and other characteristics, including any functionality. (A more detailed example of a representational difference analysis in accordance with the invention may be found in the "Materials and Methods" section. )
Additionally, the invention encompasses methods for discovering and applying genes and their encoded proteins, which are involved in the formation of white- blood cells. Since icefish blood contains only white- blood cells (i.e., no contaminating erthrocytes) , cDNA libraries from their blood should be highly enriched for genes whose expression regulates lymphopoiesis (B and T cell formation) and myelopoeisis (myeloid cell development) . Enrichment for unknown lymphopoietic and myelopoietic genes can be accomplished by subtracting a blood cDNA library from C. acera tus with an ensemble of genes that are already known to participate in white- blood cell formation. For instance, isolation of either peripheral, mononuclear lymphocytes (for T or B cell lineages) or myeloid cells (for monocyte/macrophage lines, neutrophils, and basophils) , can be done through centrifugation of C. acera tus blood on Percoll and/or Ficoll density gradients and removal of the appropriate, corresponding density gradient band. The RNA of the particular cell type is used to make corresponding cDNA clones, which are then subjected to "normalization" procedures, as known in the art, to subtract out common clones, while "unique" clones are retained, resulting in clones enriched for lymphopoiesis- or myelopoiesis- related genes. Alternatively, one could use a variation of the representational difference analysis subtractive cloning, using an icefish (e.g., C. aceratus) genome as the tester DNA for unique lymphopoiesis or myelopoiesis genes, while a red-blooded fish genome (e.g., any of the red-blooded fish of Notothenioidei suborder: spiny plunderfish, dragonfish, plunderfish, or rock-cods) serves as the driver DNA for subtracting out common clones.
Potential applications of newly identified, rare, lymphogenesis-related genes or clones include, for example, probes for diagnosis and therapeutics for treatment of leukemias (ly phomas, myelomas, etc.). Moreover, icefish produce large numbers of thrombocytes, the fish equivalent of the platelet-forming megakaryocytes of mammals. Therefore, the gene screening and discovery approach of the invention can also be directed to discovering, from icefish, novel factors for controlling blood clotting in animals, including mammals, particularly humans. Discovery of thrombopoiesis-related cDNA and genes would require isolation of thrombocytes from a white-blooded icefish, by, e.g., centrifugation of its hemapoietic cells on a density gradient such as a Ficoll or Percoll and taking the cells from the appropriate band. Those cells (i.e., thrombocytes') RNA is prepared according to known techniques, and at least one thrombocytic cDNA library is created from the RNA, by known techniques. Normalization or substractive analysis of the icefish thrombocytic cDNA library is performed to screen out common clones. The remaining cDNA clones are screened against a suite of known thrombopoiesis genes and analyzed for rare, previously unidentified genes involved in blood-clotting.
The novel hematopoiesis-related genes and encoded proteins thus far discovered and others currently undergoing identification by the method of the invention, are likely to offer new routes for pharmacological treatment of blood diseases.
Another species that might also serve as a good hematopoiesis gene-screening system may be immature, Anguilliform eels, which have been suggested to lack red- blood cells at early developmental stages.
The invention is further described with reference to the following, non-limiting example of using RDA to uncover new erythrocytic genes.
Example : PCR RDA-based screening for erythropoietic genes
Using a RDA screening as described above and later in greater detail in the "Materials and Methods" section, three rounds of subtraction were performed to enhance recovery of N. coriiceps cDNAs that were not present in the head kidney of the hemoglobin-lacking icefish, C. acera tus . Proof of the effectiveness of the present subtractive- analysis screening method in selecting for certain hemapoietic genes was established by the isolation of partial α-globin and β-globin cDNAs, which represented approximately 30% of the total, N. coriiceps-derived RDA clones (see Table I) . These globins are absent from C. aceratus . Three mitochondrial cDNAs, encoding portions of NADH dehydrogenase subunits 4 and 5 and cytochrome c oxidase, were also abundant RDA products (10%, 2.5%, and 2%, respectively) . To eliminate these five known, "background" genes, all 316 RDA clones were spotted onto nylon membranes and probed with the corresponding RDA fragments .
Table I.
Dot Blot Screening of Several Representational Difference Analysis Products
Gene Probed No . of clones Total Percentage positive Clones of Total α-globin 38 316 12.0% β-globin 52 316 16.5%
RDA65 6 316 1.9%
RDA5 8 316 2.5%
RDA2 33 316 10.5%
The remaining, "background-cleansed" clones (179 total) were sequenced manually by the dideoxynucleotide chain-termination method, and the sequences were assembled to yield 45 contigs using DNASTAR. The deduced protein sequence from each contig was compared to the protein sequences of the SWISS-PROT database and to the EpoDB database of erythrocytic proteins using the BLAST-X algorithm. The contigs were divided into three groups of sequences: known, uncertain, and unknown, based on similarity to proteins in the two databases. Twenty-two percent (22%) of the 45 contigs showed strong similarity to known proteins. Examples included erythrocyte-specific β- tubulin, α-amylase, 12-lipoxygenase, F-actin capping protein, proteosome component C13, the DEZ receptor of developing osteoblasts, and S-adenosylhomocysteinase. A second group of RDA clones was categorized as "uncertain" . These proteins (corresponding to 18 contigs or 40% of the background-cleansed isolates) gave probability scores (0.003-1.0) to known proteins that reduce confidence in the matches. Considering that the databases contain primarily mammalian protein sequences, the lower probability scores for these teleost clones do not eliminate them as potential "knowns". The uncertain matches included the GAG polyprotein, the eosinophil peroxidase precursor, the myeloperoxidase precursor, hematopoietic lineage cell- specific protein, and β-tryptase. The third group contained 17 contigs (38% of cleansed isolates) whose deduced protein sequences failed to match any proteins in the two databases . Some of these clones may have been derived from 3 ' -untranslated sequences of the subtracted mRNA population. Nevertheless, the isolation of full-length cDNAs, whose coding sequences corresponded to some of the unknown RDA probes, demonstrated that unique, hematopoietic genes were recovered by the subtractive strategy of the invention.
Northern Analysis of the Expression of the RDA Products
To validate the subtracted clones, Northern slot blots containing total RNAs from hematopoietic (spleen, head kidney, and whole blood) and non-hematopoietic (brain, heart, liver, trunk kidney, and gills) tissues of N. coriiceps and C. aceratus were probed with cDNAs representing the 45 RDA contigs. Figure 2 shows a Northern slot blot produced using total RNAs from various tissues of either N. coriiceps ( N. c. ) or C. acera tus ( C. a . ) . The blot was hybridized to the N. coriiceps 600 bp α-globin cDNA and washed at high stringency. Hybridization signals were detected after exposure to X-Ray film (Kodak) for two hours. Figure 2 shows that α-globin was strongly expressed by the hematopoietic tissues of the red-blooded rock-cod, as anticipated, and was completely absent from tissues of the hemoglobin-lacking icefish. Hence, these results demonstrate the effectiveness of the screening method of the invention in uncovering erythropoiesis-related genes. Figure 3 depicts a Northern slot blot analysis of the tissue-specific expression patterns of five representational difference products (RDA15, RDA23, RDA34, RDA263, RDA289) . Northern slot blots were produced using N. coriiceps ( N. c. ) or C. acera tus (C. a.) total RNAs from various non-hematopoietic tissues brain (B) , heart (H) , liver (L) , trunk kidney (TK) , and gill (G) as well as hematopoietic tissues spleen (SP) , head kidney (HK) , and whole blood (BL) . Figure 3 thus illustrates that five "unknown" RDAs were expressed differentially by the tissues of the two fish. In general, the RDA clones were expressed preferentially in the hematopoietic tissues of N. coriiceps . Furthermore, most of the RDA products present in the head kidney of N. coriiceps were absent from the head kidney of C. aceratus, consistent with the latter 's erythrocyte-lacking phenotype . Interestingly, some RDA clones (RDA23, RDA289) expressed by the hematopoietic tissues of N. coriiceps were also found to be expressed by the spleen, liver, and/or trunk kidney of C. aceratus . These RDA clones may represent critical hematopoietic genes whose functions, in the absence of head kidney erythropoiesis, have been transferred to other sites in the icefish.
In Situ Hybridization of RDA Probes
The cell-specific expression of the RDA clones was analyzed by in situ hybridization of RNAs transcribed from the probes to blood smears and tissue prints of N. coriiceps and C. aceratus. To validate the procedure, pilot studies utilizing the α-globin cDNA from N. coriiceps
(14) were performed.
Figure 4 shows the results of in situ hybridization of the α-globin RNA transcripts to blood cells of red- and white-blooded Antarctic fish species. Blood smears were prepared from the red-blooded N. coriiceps and the white- blooded C. aceratus as discussed. RNA probes, either antisense or sense, were hybridized to slides in tandem. Cells were counter-stained with Methylene green for contrast. Panels A and B represent N. coriiceps while Panels C and D represent C. aceratus . Note that the antisense transcript of α-globin stained intensely the cytoplasm of the red blood cells of N. coriiceps, as expected, whereas the sense transcript did not stain these cells. Neither antisense nor sense transcripts stained the blood cells of C. aceratus . Thus, rock cod erythrocytes contain α-globin mRNA, whereas the blood cells of icefish do not. (Blood cells were photographed using a SPOT-32 digital camera system attached to a Nikon 800 series microscope. All pictures were taken at 400X magnification. )
Figure 5 shows the results of in situ hybridization of RDA15 clone. Blood smears for N. coriiceps or C. aceratus were hybridized with antisense or sense RNA probes transcribed from RDA15. Slides were counter-stained with methylene green. Panels A and B represent N. coriiceps while panels C and D represent C. aceratus . The positive signal obtained in N. coriiceps red blood cells with the antisense RNA probe demonstrates the presence of the corresponding mRNA. The sense control showed no staining, and neither sense nor antisense RNAs gave a signal for the icefish blood cells. Photomicrographs of the slides were taken at 400X magnification on a Nikon 800 microscope.
Figure 6 shows the results of in situ hybridization of the RDA197 clone. Blood smears for N. coriiceps or C. aceratus were hybridized with antisense RNA probes transcribed from RDA197. Slides were counter- stained with methylene green. Panel A represents N. coriiceps while panel B represents C. aceratus . The mRNA corresponding to the RDA197 clone is present in blood cells of N. coriiceps and absent in those of C. acera tus . Photomicrographs of the slides were taken at 400X magnification on a Nikon 800 microscope.
Therefore, Figures 5 and 6 demonstrate that the RDA15 and RDA197 antisense probes detected mRNAs in erythrocytes of N. coriiceps, that the sense probes gave no reaction, and that the white cells of C. aceratus blood lacked the message.
Figure 7 shows the results of in situ hybridization of the RDA23 clone. Head kidney tissue prints for N. coriiceps or C. aceratus were hybridized with sense or antisense RNA probes transcribed from RDA23. Slides were counter-stained with methylene green. Panel A represents N. coriiceps head kidney while panel B is C. aceratus head kidney. (Photomicrographs of the slides were taken at 400X magnification on a Nikon 800 microscope.) When RDA23 was hybridized to head kidney prints from N. coriiceps and C. acera tus (see Figure 7), the antisense probe produced a strong signal in nascent N. coriiceps erythrocytes, whereas cells resembling proerythroblasts from C. aceratus head kidney gave a faint color reaction. The latter result suggests that the RDA23 mRNA accumulates in late-stage rock-cod erythrocytes and that the icefish may possess red- cell precursors that are blocked in terminal differentiation.
Library Screening of Unknown RDA Products
The invention also encompasses screening a Notothenia coriiceps spleen cDNA library for full-length clones corresponding to the "unknown" RDA products isolated by the erythrocytic gene screening method. The first two clones chosen were RDA23 and RDA15.
Upon complete sequencing, the RDA23 product was found to be a chimeric clone composed of two subtraction products. Thus, two distinct clones, termed "23-8" and "23-10", were recovered from the N. coriiceps splenic cDNA library using the RDA23 product as a probe.
A schematic representation of the cDNA 23-8 clone is shown in Figure 12A, while Figure 12B is a Northern slot blot showing cDNA 23-8 's comparative tissue distribution in N. coriiceps and C. aceratus . The 23-8 cDNA probe detected high levels of mRNA in the spleen, head kidney, and trunk kidney (i.e., hemapoietic organs) of N. coriiceps, but detected significant mRNA only in the spleen and not the head kidney or blood of C. acera tus . The cDNA 23-8 clone, roughly 5 kb in length, is currently being sequenced to completion. The thus-far deduced sequence of clone 23-8 appears to encode a protein that, when compared to the protein sequences of the SWISS-PROT database, includes a conserved, approximately 100 amino-acid B30.2 domain and an adenylosuccinate synthetase domain. Interestingly, the B30.2 domain is also present in nuclear transcription factors such as the RET finger protein (a potential zinc- finger transcription factor) and pyrin, and in trans- membrane receptor or adhesion proteins like the recently described erythroid membrane-associated protein (ERMAP) , a single-pass membrane receptor possibly involved in differentiation of murine proerythroblasts (21) . ERMAP appears to mediate interactions between developing red cells and the stroma of the bone marrow, and it may be involved in a tyrosine kinase signalling pathway or pathways. Thus, clone 23-8 may encode a novel membrane receptor or transcription factor involved in erythroid maturation, thereby making it a potential drug target for stimulating blood formation in anemic patients.
Clone 23-10 ( also identified as cDNA 23-10/4 in Figure 13 ) is approximately 1 kb long and has the following sequence ( SEQ ID NO : 1 ) :
GAATTCGCGG CCGCTGCCTC CTCCTGCAGC TCCTGCTTTT CAGATTCAAT 50
AGTCTCCTAC TACTGAAAAG CTCAAAACGA CTTAAATAAC ATGTCGGACG
100
AAGGTAAACT CTTCATCGGT GGTCTCAGCT TCGACACCAA CGAAGAATCT
150 CTGTCTGCGG CCTTCTCCAA GTATGGAACC ATCGAGAAGG TGGACGTGAT
200
CAGAGACAGA GAGACCGGGA ATTCCCGCGG TTTCGGCTTC GTGAAGTACG
250
ACAACGCCGA GGATGCCAAA GACGCAATGG ACGGCATGAA CGGAACCTCC 300
CTCGATGGCC GGTCAATCCG CGTCGACGAG GCAGGTGAAG GCGGTGGTCC
350
TAGGGGTGGC GGCGGATCAA GAGGCGGGCG CGGAAGAGGC GGATATGGCG
400 GTGAGAGAAG CTATGGCGGA GGAGACAGAA GCTATGGCGG CGGCGGCGGC
450
GGCGRAGGAG ACAGAAGCTA TGGCGGCGGC GGAGGAGACA GAAGCTATGG
500
CGGCGGAGGA GGAGAAAGAA GCTATGGCGA AAGATCAAGC TACGGATCCG 550
ACAGTCGTTC CGGCGGCGGC GGTGGCTACA GATCCGGCGG AGGCAGCGGC
600
GGATACTCAC GAGGTGGTGG AGGAGGAGGA GGCGGCGGCG GCTACAGAGA
650 CAACAGAGGC AGTCGCGATG GCGGATACGA ATAAAGCATT CTTCCCGCTG
700
GCTTAAAAAC AGTGGTTTAA ATATAATTGT GTTGATATGG ACTAAGTAAA
750
AGTTGTGTTT TCCCAGCAAG CTCCATTCAC GGTGACAGAG CGCCATAATA 800
CTTTGACTTT GATTTGATTT TGATAATAAA CAGCCTCAGG CCTTGTGAGT
850
CACAAATAGG TGAGTGTTTT TTTTATTGTT ATCCGGTAGC CATTGCAAGC
900 AGATGAACTC GTCGCCTAGT GACACACAAG TGACTCCRGA TAAACTCTTA
950
ACATGCTCTT TGATCCAGTT TCAACATTTT CTACTTACCT CTGCTTTTTG
1000
AGGGAGAATT CTCATAATGT CTGATCGAGA GGATAGATAG TCAGAGAGCA 1050
AAACAGTCAC CCTGAGAATA TTCTGTGAAT CCATTGGGCT AAATCCTTCG
1100
GTCAATTTCA CGGAAATATA AGATTTTTTA TTTTACCCCA CACCATGTAA
1150 CTAGTTAATG TATTTTGCCT GGGATATTTG TTGCAGGGTA AAATTGTCAA
1200
TTTCCAGTTA AAGTATGTCT AAAGAAATCC ACAATCAATC CTAAATCCTG
1250
CAATGATATC AACTCTGCTG TTCCCAGTCA GTGTAGAGTA AGTCCACACT 1300
GACTCTGTAT GTGATCATAA TAAAGGTTTA CAGCGGCCGC GAATTCTTTT
1350
GCTT (SEQ ID NO: 1) The clone 23-10 cDNA, i . e . , SEQ ID NO : l , , can be used as a nucleic acid probe, with the probe also optionally including up to another 100 on the 5 ' end of SEQ ID NO : l (preferably in a range of about 50-100 bases ) , or up to about 1 kb on the 3 ' end of SEQ ID NO : l (preferably in a range of about 50-1000 bases ) , or both .
Computer modeling programs and comparative analysis with known sequences have helped to preliminarily identify a putative amino acid sequence encoded by cDNA 23-10 . Clone 23-10 represents the first finding, in an Antarctic fish, of what appears to be a gene encoding a cold- inducible RNA-binding protein (CIRP ) that is orthologous to one found in Xenopus, XCIRP ( 22 ) , with which it shares about 53% similarity . The putative N. coriiceps CIRP protein also shares about 51% similarity to the human form and 50% similarity to the mouse form . Thus , clone 23-10 appears to encode a ribosomal protein helpful in stabilizing RNA binding to ribosomes , particularly at temperatures significantly below 37 ° C . Library screening using RDA15 yielded two cDNA clones ,
15- 9 and 15-17 ( also designated cDNA 15-17 / 13 , schematically represented in Figure 14A) . Clone 15-17
( approximately 2 kb in length ) was partially sequenced ( SEQ ID NO : 2 ) , as follows , and found to match to a maj or histocompatibility complex (MHC ) class I gene :
GAATTCGCGGCCGCTTGTGTTTCTGTGGATAAAGAACCTTTCACAGAGAAAGCCTCGTGAGATCAAG ATGAAGATGTTGCTTTTTCTGCTTTTCCTGGGAACAGTAGGCCCTCACTGCACATCTGCACGGACTC ACTCTCTGATGAATTTCTACACTGCGTCCTCTGGAGTCCCAAACTTCCCAGAGTTTGTGGCTGTTGG GTTGGTTGATGACGTTGAGATGGTGCATTACGACAGCAACACCAAGAGAGCAGAGCCCAAACAGGAC TGGATGAAGAACATCATAGACGAGGATCCTAATTACCGGGAGGGGCAGACTCAGATCTTTCAGGGTA ACCAGCAGAACTTCAAAGTCAACATTGAAATTGTAAAGCAGCGCCTCAACCAAACTGGAGGTGTCCA CATTGTCCAGCTGATGTACGGCTGTGATTGGGATGATGAGACTGGTGAGGGCAAAGGTTATTGTAAC CATGGTTTTGATGGAGAAGACTTCATAGCACTGGACCTGGAGACAGAGACATGGACCGCTCCAAGAC GAGAGGCTGTCCTCACCAAACAGAAGTGGGATAAGAACAAAGCTCAGATGGCCCAGGACAAGAACTA
CTTCACCCAGAGATGTCCTGAGTATCTGAAGAAGTATGTGAAGCTTGGGAGGAGCTCTCTGATGAGA ACAGAGATCCCCTCAATGTCTCTGCTCCAGAAGTCCCCCTCCTCTCCAGTCAGCTGCCACGCTACAG GTTTCTACCCGGACAGAGCCGCCATGTCCTGGAGCAGAGACGGAGAGGAGCTTCAGGACGACAACAT GGACCACGGAGAGATCCTGCCCAACCACGACGGATCCTTCCAGATAGCTTGGACCTGGACGTCTCCT CATTCCCCGCTGAAGACTGGGGCAAGTACCGATGTGTGTTCCAGCTCTCTGGGTGAAGGAGGACCAC GTCATCGAACTGGGCTCAGCTGTGATTCAGGACCAACAGAGGGAATCCCCTCCTCTTCATTCATCAT CGGTGCTGAACGGCTGGTCTTCTCCTCCTCCTCCTCCTGGGATGGATTCCTGGTTACAGGAGAGGAC GACAGAAGAACACTCCTTTCGGCTTCA (SEQ ID NO: 2)
Figure 14B shows that clone 15-17/13 cDNA hybridizes to mRNA in essentially all N. coriiceps tissues, especially in its blood. (Its expression in red blood cells may possibly serve as a mechanism of self-recognition.) In contrast, the blood and trunk kidney of erythrocyte-lacking C. acera tus give no or only a faint mRNA signal when probed with cDNA 15-17. This expression pattern again proves the success of the method of the invention and resulting RDA products in uncovering red-blood cell specific genes and gene products. Clone 15-9 was found to encode β-microglobulin, and appears to be a spurious isolate.
Also isolated by the present screening method was clone 162-3, an approximately 1-kb cDNA which, based on preliminary data, appears to encode the Septin-like Protein Sint 1 (see Figure 15A) . Its occurrence is high in N. coriiceps head kidney and spleen, and even stronger in liver, spleen, trunk kidney, and head kidney of C. aceratus, as shown in the Northern slot blot in Figure 15B. The septins play critical roles in cell division, probably by serving as a scaffold for assembly of signalling proteins at the cleavage furrow of dividing cells. Furthermore, fusions of septin-like genes to the MLL protein gene, through chromosomal translocation, have been implicated as mutations that may contribute to development of acute myeloid leukemia. This 162-10 clone may represent a novel septin variant, and may be useful as a nucleic acid probe consisting essentially of SEQ ID NO: 3
(i.e., SEQ ID NO: 3 optionally including up to 50-100 bases on either the 5' end, up to 1000 bases on the 3' end, or both), and as a diagnostic tool for acute myeloid leukemia. The 162-3 product may also serve as a novel target for chemotherapeutic agents directed against various cancers.
Also isolated and sequenced has been clone 295-5, a 1- kb cDNA (SEQ ID NO: 3) : GAATTCGCGGCCGCTAGGAGACAGACCTACCGGCGGTATAACGCACACCATGGCAGAGCAGGAACCC ACACCCGAGCAGCTGGAGGCGCTTGCAGCAGCCAATGACGAGCCGGAGAACCCTCTCAACTACAAAC CCCCCGCCGCCAAGAGCCTACAGGAGATCCAGGAGCTGGACCAGGATGACGAGAGCCTGCGCAAGTA CAAGGAGACCCTGCTGGGCAACGTGGCCTGTGTGGCAGACCCCTCGGCCCCCAACGTGCAGGTGATA GGGATGACTCTGAAGTGTGAAACGGCCCCTCACCCTCTGGTGCTCGACCTGACGGGAGACCTGACTA AATTCAAGAAGAGCCCATTTGTTCTGAAGGAAGGGGTGGAATATAGAATACAGATCAACTTCAAGGT CAACAAGGATATTGTGTCCGGCATGAAGTACACTCAGCAGTCATTCCGGGGAGGAATTAAGGTTGAG AAGTCTGACTACATGGTGGGCAGCTATGGCCCGAGACCCTCTGAGGAGTACACGTTCGTCACCCCCA TGGAGGACGCCCCCAAAGGGATGATCGCCCGCGGCACCTACACCATCAAGTCCAAGTTCACCGACGA CGACAAGCACGACCACCTCTCCTGGGAGTGGTGCATCGCGATCAAGAAAGACTGGACCGAATGATTC GCCCTCCACGACTTCCTCCGCTTGGTTCCTCCTTTCCTTTCTTGCTGTCATTCCATTTTATCTGTCT GCATTACGTGTTGATTTGAGATGTCGCTCTCTCCGTCCATCGACAACCCCCCCCCCCCCGCTCTTTA CAGGGTTTCTAAATTCCAATCACCTCCTTTCCATCCTAGCGCTTTCATTCATTTCCACCTTTCTGCT AAGCTATTCCAAAGGAGAAAGCAACCGATGCGCACGATCCAGATTTCTAGTTGGTTATTAAAGAAAA AATTAGTA (SEQ ID NO: 3)
Clone 295-5 has been identified as encoding a protein homologous to the ubiquitously expressed Rho-GDI Dissociation Inhibitor 1 (see Figure 16A) . However, as shown in Figure 16B, the distribution of Rho-GDI 1 appears to be specific for the blood-related organs (similar to the distribution of Rho-GDI Dissociation Inhibitor 2) , giving a strong mRNA signal in N. coriiceps spleen, head kidney and blood) and no or low mRNA signals in those same organs in C. aceratus . This family of Rho-GDI factors interacts with G proteins (e.g., Rho) to control the rate of GTP/GDP exchange. Hence, the clone 295-5-encoded protein is likely to perform an important role in G-protein-coupled signalling pathways involved in blood-cell differentiation. Determination of the actual protein sequence encoded by this cDNA is underway.
Currently, subtractive analysis products RDA263 and RDA289 are being used as probes to screen the spleen cDNA library, and sequencing of their cDNAs is in progress.
Morphological Analysis of Hematopoietic Tissues from Antarctic Fish If icefish are blocked in an early stage of the erythropoietic program, then one would expect to recover by RDA subtraction, one or more red-cell genes encoding structural proteins. However, RDA products encoding Band 3, Band 4.1, and spectrins were conspicuous in their absence. Perhaps the icefish C. aceratus -has retained "proerythroblast-like" cells in its hematopoietic tissues that are, nonetheless, blocked in terminal differentiation. To address this question, spleen prints from both red- blooded Antarctic fish species ( G. gibber if rons and N. coriiceps) and white-blooded icefish (C. acera tus, C. rastrospinosus, and P. georgianus) were examined for the presence of cells that were similar morphologically to proerythroblasts. Using Wright/Giemsa staining, proerythroblasts can be distinguished by their large, purple-pink nuclei and their small volume of deep blue cytoplasm, characteristics that are not shared by myelocytes. Figure 8 demonstrates that spleens of the three icefish species contain cells that are similar to presumptive proerythroblasts of the two red-blooded species. Thus, the morphological data are consistent with the possibility that icefish contain cells of the erythroid lineage that are unable to differentiate into mature red cells. (Specifically, for Figure 8, spleen tissue prints were stained with Wright/Giemsa and photographed at 400X magnification (panels A through D) or 600X magnification with immersion oil (panel E) . White-blooded fish species were presented by: (A) Chionodraco rastrospinosus; (B) Chaenocephalus acera tus; and (C) Pseudochaenichthys georgianus . Red-blooded fish species were represented by:
(D) Gobionotothen gibber if rons; (E) Notothenia coriiceps .
(Abbreviations used for cell types: ProE = proerythroblasts, lymph = lymphocytes.) Southern Analysis of Erythropoietic Genes
It has been demonstrated previously that most of the adult α/β-globin gene complex has been deleted from several species of the hemoglobin-lacking icefish (11;14). Thus, it appeared plausible that other genes required for red cell development may also have been deleted from icefish genomes. Representational difference analysis, performed as in Example I, did not yield common erythrocytic genes, such as Band 3, Band 4. 1 and others typically expressed during terminal erythrocyte differentiation. To determine whether these genes remain in icefish genomes, testicular DNAs from C. acera tus and N. coriiceps were probed with vertebrate cDNAs that encode various hematopoietic proteins. Figures 9-11 show the hybridization patterns for the murine EpoR cDNA, and for zebrafish Band 3, and α- spectrin cDNAs .
An essential component of the erythrocyte developmental program is the erythropoietin receptor
(EpoR) . Erythropoietin is a hormone required for the maintenance and proliferation of red cells (2). Its receptor is expressed at high levels in blast-forming unit erythroid (BFU-E) colonies, and expression declines as the BFU-E cells mature. Figure 9 shows a Southern hybridization of the murine erythropoietin receptor cDNA to genomic DNAs of different fish species. A 1.8 kb cDNA fragment for EpoR was hybridized to genomic DNAs from zebrafish, C. aceratus and N. coriiceps . Genomic DNAs were digested with Pstl (lane P) , Hindlll (lane H) , and BamHI (lane B) . Molecular weight markers (λBstEII) are labeled at right. The results in Figure 9 show that the murine EpoR probe hybridized strongly to genomic DNAs from C. aceratus and N. coriiceps, yielding similar fragment patterns . Thus, the EpoR gene, whether active or inactive, is present in the genome of a white-blooded icefish.
Band 3 is an essential multipass membrane protein of the red cell that acts as an anion transporter for removal of the waste product bicarbonate. Figure 10 shows a Southern hybridization of zebrafish Band 3 cDNA to genomic DNAs of different fish species. A 600-bp cDNA fragment for Band 3 was hybridized to genomic DNAs from zebrafish, C. aceratus and N. coriiceps . Genomic DNAs were digested with Pstl (lane P) , Hindi11 (lane H) , and BanMI (lane B) . Molecular weight markers (λBstEII) are labeled at right. Figure 10 demonstrates that the icefish genome hybridizes to a zebrafish Band 3 DNA probe, but at reduced intensity relative to that observed for N. coriiceps . This suggests that the icefish genome may contain a truncated, potentially inactive Band 3 gene.
The icefish genome was examined for the genβ encoding α- spectrin. This structural protein forms a heterodimer with β-spectrin and polymerizes to form long thin rods found beneath the red cell membrane. Figure 11 is a Southern hybridization of zebrafish α-spectrin cDNA to genomic DNAs of different fish species. A 1.0-kb cDNA .fragment for α-spectrin was hybridized to genomic DNAs from zebrafish, C. aceratus , and N. coriiceps . Genomic DNAs were digested with Pstl (lane P) , Hindi11 (lane H) , and BamHI (lane B) . (Molecular weight markers (λHindlll) are labeled at right.) Figure 11 demonstrates that sequences complementary to the zebrafish α-spectrin probe are present in red- and white- blooded Notothenioid fish.
Materials and Methods
Specific details relating to a preferred embodiment of the screening method of the invention are herein described. Collection of Fish Samples
Fish were collected from Antarctic waters near Low and Brabant Islands in the Palmer Archipelago by bottom trawling from the R/V Polar Duke or the ARSV Laurence M. Gould. The fish were transported alive to Palmer Station, Antarctica, where they were maintained in seawater aquaria at about -1°C to +1°C. Species included three icefish { Chaenocephalus aceratus, Pseudochaenichthys georgianus, Chionodraco rastrospinosus) and two rock-cods (Notothenia coriiceps, Gobionotothen gibberifrons) . Zebrafish { Danio rerio) were maintained at 25°C in freshwater tanks at Northeastern University under a 12:12 h light/dark cycle.
Tissue Sampling and Slide Preparation
Whole blood (5-10 ml) was collected from live fish by caudal venipuncture using heparinized syringes. Blood cells from the icefish species were pelleted by centrifugation at 1000 rpm in an IEC clinical centrifuge at room temperature. The cell pellets were resuspended in Notothenioid Ringer's solution (260 mM NaCl, 5 mM KC1, 2.5 mM MgCl2, 2.5 mM CaCl2, 2 mM NaHC03, 2 mM NaH2P04, 5 mM glucose) for preparation of blood smears. Whole blood from red-blooded species was used undiluted for smear preparation. Solid hematopoietic tissues (head kidney or spleen) from the five Antarctic species were dissected, and tissue prints were made by pressing tissues gently on glass slides. Microscope slides were fixed for 2-5 min in 100% methanol (room temperature) and then air-dried. Slides were stored in boxes and transported to Northeasten University from Palmer Station at ambient temperature. Other specimens of head kidney, spleen, and blood were snap-frozen in liquid nitrogen and stored at -70°C. Preparation of mRNA and Synthesis of cDNA
Cytoplasmic RNA from hematopoietic (head kidney, spleen, and blood cells) and non-hematopoietic (brain, gill, heart, liver, trunk kidney) tissues was isolated using a modification of the acid guanidinium isothiocynate/phenol/chloroform method (14) and then stored in ethanol at B70°C. Poly (A)+ mRNA was purified from the head kidneys of N. coriiceps or C. aceratus via affinity chromatography on oligo (dT) -cellulose . Double- stranded cDNA was synthesized using poly (A) + mRNA; first- strand synthesis was primed with oligo-dTι5 and second- strand synthesis was performed by standard protocols (15) .
Representational Difference Analysis Representational difference analysis, as described by Hubank and Schatz (13) , was performed on red-blooded N. coriiceps and white-blooded C. aceratus fish. To create representations of the head kidney cDNAs of the two fish, double-stranded cDNAs from N. coriiceps (tester) and C. aceratus (driver) (2 μg each) were digested by the enzyme pnII (New England BioLabs) . The resulting fragments were isolated by ethanol precipitation in the presence of carrier glycogen (2 μg) . Oligonucleotide primers, R-Bgl-12 (5'-GATCTGCGGTGA-3' ) (SEQ ID NO: 4) and R-Bgl-24 (5'-AGCACTCTCCAGCCTCTCACCGCA-3' ) (SEQ ID NO: 5), were annealed to create double-stranded adapters. The adapters were ligated to the Dpnll-digested DNA fragments from each species by incubation at 50°C for 1 minute followed by cooling to 10°C over about 1 hour. T4 DNA ligase (40 U) was added to each sample, and the samples were incubated overnight at 16°C. Ligations were diluted in TE (pH 8.0) to a final volume of 200 μl . The ligation products were amplified in IX PCR buffer (66 mM Tris-HCl (pH 8.8), 4 mM MgCl2, 16 mM (NH4) 2S04, 33 μg/ml bovine serum albumin) containing the four deoxynucleotides (dATP, dCTP, dGTP, dTTP [3 mM each] ) and 2 μg of the R-Bgl-24 primer in a total reaction volume of 200 μl . Prior to amplification, the samples were treated at 72°C for 3 min to melt the 12- mer adapter, 5 U of Klentaq DNA Polymerase (Clontech) was added to each, and the samples were incubated for 5 min at 72°C to fill in the ends. PCR was performed for 20 cycles according to the following schedule: 1) denaturation steps, 95°C, 1 min; 2) annealing and extension steps, 72°C, 3 min; 3) a terminal extension, 72°C, 10 min; and 4) final soak at 4°C. For each fish, four PCR reactions were combined to give a total volume of 800 μl, and the samples were extracted once with phenol/chloroform/isoamyl alcohol (25:24:1) followed by one extraction with chloroform/isoamyl alcohol (24:1). Representations were then precipitated and resuspended to a concentration of 0.5 mg/ml in TE.
To create the driver DNA population, amplified cDNA representations (300 μg) from C. aceratus were digested with DpnII for 4 h, purified by phenol/chloroform extraction and precipitation, and resuspended to a final concentration of 0.5 mg/ml in TE. To create the tester DNA population, 20 μg of N. coriiceps cDNA representations were digested with DpnII, electrophoresed in a 1.2% agarose gel in IX TAE, and purified using the Qiaex II gel extraction kit (Qiagen) . Two μg of purified tester were ligated to J- oligo adapters (J-Bgl-12, 5' GATCTGTTCATG 3' (SEQ ID NO: 6) and J-Bgl-24 5' ACCGACGTCGACTATCCATGAAGA 3' ) (SEQ ID NO: 7)), under the conditions described for the R- Bgl adapters (Figure 1, step 1-A) . After overnight ligation, the tester was diluted with TE to a final concentration of 10 ng/μl . For the first subtractive hybridization, 0.4 μg of the tester N. coriiceps DNA was combined with 40.0 μg of driver C. aceratus DNA (i.e., the latter is present in an excess over the amount of tester DNA provided; in this case, 100- fold, though other amounts could be used) . The pooled DNAs were extracted with phenol/chloroform, and the DNA collected by ethanol precipitation. The pellet, containing both driver and tester DNAs, was resuspended in 4 μl EE 3X buffer (30 mM EPPS, pH 8.0 (Sigma), 3 mM EDTA) . The driver/tester DNA solution was heated to 37°C for 5 min, overlaid with mineral oil, denatured by incubation for 5 min at 98°C, and cooled to 67°C. One μl of 5 M NaCl was added and the samples were incubated at 67°C for 20 h
(Figure 1, step 1-B) . After removal of mineral oil, 8 μl TE (pH 8.0) and 5 μg/μl yeast transfer RNA (tRNA) were added to the DNA solution. An additional 25 μl of TE (pH 8.0) was added, and the solution was pipetted vigorously and then diluted to 400 μl with TE (pH 8.0). Twenty μl of this sample were diluted 1:10 with 10X PCR buffer and 10X nucleotide mix, and the solution was heated at 72°C for 3 min to remove the 12-mer. Five U of Klentaq polymerase were added, the solution was heated at 72°C for 5 min, then 1 μl of J-Bgl-24 primer (2 mg/ml) was added. This sample, which corresponded to the first-round subtraction products, included double stranded (ds) tester DNA, single-stranded (ss) tester DNA, tester/driver hybrids, double-stranded (ds) driver DNA, and single-stranded (ss) driver DNA, with all double-stranded DNA molecules having their single- stranded ends filled in, so as to blunt-ended:. The sample was amplified by PCR for 10 cycles according to the following schedule: 1) denaturation steps, 95°C, 1 min; 2) annealing and extension steps, 72°C, 3 min; 3) a terminal extension, 72°C, 10 min; and 4) cooling to room temperature (Figure 1, step 1-C) . The PCR samples were then extracted with phenol/chloroform and resuspended in 40 μl of 0.2X TE (pH 8.0). Half of this amplified sample was incubated with Mung Bean nuclease in IX digestion buffer (New England Biolabs) for 35 min at 30°C to digest single-stranded DNA. The reaction was stopped by addition of 50 mM Tris-HCl (pH 8.9) and incubation at about 98°C for 5 min. After treatment with Mung bean nuclease, the samples were incubated with 2 μl J-Bgl-24 primer (1 mg/ml) for about 1 minute at about 95°C and cooled to approximately 80°C. Five units of Klentaq polymerase mix were added and PCR was performed for 18 cycles according to the following schedule: 1) denaturation steps, ~95°C, 1 min; 2) annealing and extension steps, ~70°C, 3 min; 3) a terminal extension, ~72°C, 10 min; and 4) final soak at 4°C (Figure 1, step 1- D) . The PCR samples were extracted with phenol/chloroform and resuspended to a concentration of approximately 0.5 mg/ml in 100 μl TE (pH 8.0). This procedure gave the first Difference Product, termed "DPI" (i.e., the PCR strategy resulted in exponential amplification of double-stranded tester cDNA that should be enriched for DNA fragments of genes expressed by the tester N. coriiceps head kidney but not by the driver C. aceratus head kidney) .
Difference Product I (DPI) was digested with DpnII as before to create representations. Primers N-Bgl-12 (5' GATCTTCCCTCG 3' (SEQ ID NO: 8)) and N-Bgl-24 (5' AGGCAACTGTGCTATCCGAGGGAA 3' (SEQ ID NO: 9)) were annealed (50°C for 1 min, then incubation at 10°C for 1 h) , and ligated to the digested DPI products (50 ng/μl) overnight at 14°C. The ligation was diluted to 1.25 ng/μl and 50 ng of N-ligated DPI were hybridized at 67°C with 40 μg driver DNA as previously described, followed by amplification (under the same cycle parameters as for DPI) , using N-Bgl-24 as primer to create Difference Product II (DPII) . DPII was digested with DpnII and annealed with J- Bgl-12/24 adapters (see protocol above) . The J-ligated DPII representations were diluted to 10 pg/μl, 100 pg of tester was hybridized to 40 μg driver, and a final PCR amplification was performed for 22 cycles (see cycle parameters for DPI) to yield Difference Product III (DPIII) .
Difference Profuct II (DPIII) was digested with DpnII, and the DNA fragments were purified by Qiaex II (Qiagen) gel extraction and ligated into the BajnHI site of pBluescript KS(+) II plasmid (Stratagene) . Transformation into electrocompetent JM109 (25 μF, 1.5 mV in a BioRad Electroporator) was performed, and transformants were selected on LB agar plates (100 ng/μl ampicillin, IPTG and X-Gal) . White colonies were selected and grown in IX LB plus antibiotic, and minipreps were performed using the boiling lysis protocol (16) .
To eliminate common clones such as α-globin, the 316 clones obtained by RDA were spotted onto Magnagraph uncharged nylon membrane (Micron Separation, Inc) and screened using previously identified, but unwanted, RDA clones. The following clones were used in screening: α- globin and β-globin cDNAs from N. coriiceps (previously cloned in the lab) , cDNA clone RDA2 (encoding NADH subunit 4) and RDA10 cDNA clone (encoding cytochrome C oxidase subunit II) . Blots were hybridized in Church-Gilbert solution [7% SDS, 1% BSA, sodium phosphate buffer (pH 7.4)] at 65°C overnight. Blots were washed with 0.2X SSC, 0.1% SDS at hybridization temperature. The blots were placed onto x-ray film overnight and analyzed (Table 1). After elimination of the "background" (i.e., known genes), the remaining clones were then sequenced manually by the dideoxynucleotide chain termination method using T7 primers, USB Sequenase 2.0 (United States Biochemicals) , and 35S-labeled dATP. The sequencing products were electrophoresed on 6% polyacrylamide gels. The sequences of the clones were compared to the gene sequences of the
GenBank database (NCBI) using Blast 2.0 (17) and to those of the Erythropoiesis Database (EpoDB; University of
Pennsylvania) (18). The complete sequences of selected difference product clones (amplicons) were obtained by automated DNA sequencing on an ABI Model 370 Sequencer
(University of Maine DNA Sequencing Facility) . Sequence overlaps were established using Seqman (DNAStar) , yielding
45 distinct contigs.
Northern Slot Blots
DNA fragments resulting from the representational difference analysis (RDA) were excised from their pBS (KS+) vector by digestion with Pstl and Xbal , and the fragments were electrophoresed on 0.9% low-melting agarose gels and stored in the gel slice with water to a concentration of 5 ng/μl at -20EC. Samples (150 ng) were labeled with 32P dCTP (ICN) using a NEBlot kit (New England Biolabs) . Five μg of cytoplasmic RNA from various tissues of the tester fish, red-blooded N. coriiceps and the driver fish, white- blooded C. aceratus, were denatured in 50% formamide, 2 M formaldehyde, IX SSC at 65°C for 5 min. RNA samples were applied to an uncharged nylon membrane (Magnagraph, Micron Separation, Inc.) using a Bio-Dot SF microfiltration apparatus (BioRad) and then rinsed extensively with 10X SSC
(room temperature) . RNAs were cross-linked to the membranes by exposure to UV irradiation for 45 s using a
Spectra-Linker (Fisher) . The blots were hybridized at 65°C overnight with labeled probes in either 50% formamide, 5X SSC, 5X Denhardt's solution, 0.2% SDS or PerfectHyb hybridization buffer (Sigma) . Blots were washed to high stringency in 0.2X SSC, 0.1% SDS at 65°C. Membranes were stripped by incubation in 0.1% SDS, 0. IX SSC at 100°C for 10 min and reused a maximum of 4 times.
In Situ Hybridization
To synthesize RNAs for in situ hybridization studies, RDA clones in pBS were linearized by digestion either with Xbal or with Smal . Synthetic RNAs were labeled with digoxigenin-UTP (DIG-UTP) by transcribing the templates with either T7 or T3 RNA polymerases, to yield, respectively, antisense (experimental) and sense (control) probes following the DIG RNA Labeling protocol (Boerhinger Mannheim) (19) . Briefly, linearized plasmid DNA was extracted once with phenol followed by chloroform. After ethanol precipitation, the DNA (1 μg) was mixed with IX transcription buffer, IX nucleotide mix, 20 Units RNasin, 40 Units RNA polymerase (T7 or T3) and DEPC-treated water to give a final volume of 20 μl. The samples were incubated at 37°C for 2 h, and DIG-labeled RNAs were precipitated by addition of 0.4 M LiCl and ethanol. The cRNA probes were resuspended in 100 μl of DEPC-treated water and stored at -20°C until use. For in situ hybridization (20) , microscope slides containing blood smears, head kidney prints, and spleen prints from N. coriiceps or C. aceratus were placed into a humidified chamber, overlaid with 500 μl of hybridization buffer (50% Formamide, 5X SSC, 0.1% Tween 20, 5 mg/ml yeast tRNA, 50 μg/ml heparin), and incubated at 37°C for 1 h. After removal of the pre-hybridization solution, slides were overlaid with 500 μl of fresh hybridization buffer containing probe RNA (200 ng/ml) and incubated at 37°C overnight in the humidified chamber. Slides were washed twice with 2X SSC 37°C, three times with 60% formamide, 0.2X SSC at 37°C, twice with 2X SSC at room temperature, and then washed with 100 mM Tris-HCl (pH 7.5), 150 mM NaCl for 5 min at room temperature. The slides were overlaid with a saturated solution of blocking reagent (Boehringer Mannheim) prepared in 100 mM Tris-HCl (pH 7.5) plus 150 mM NaCl and incubated at room temperature for 30 min. Anti- DIG Fab fragments were diluted 1:200 in blocking reagent and placed onto the slides for 2 hours at room' temperature . To remove unbound antibody, slides were washed twice for 5 min each in 100 mM Tris-HCl (pH 7.5) plus 150 mM NaCl, then once for 10 min in detection buffer (Tris-HCl (pH 9.5), 100 mM NaCl, 50 mM MgCl2) . The slides were placed into detection buffer with the color reagents BCIP (0.18 mg/ml), and NBT (0.34 mg/ml) plus levamisole, an inhibitor of alkaline phosphatase (0.24 mg/ml), and allowed to react overnight at room temperature. The color reaction was stopped by addition of TE (pH 8.0) for 5 min, and slides were rinsed with distilled water prior to counterstaining with 1% Methylene Green.
Cytology
For conventional cytology, fixed blood smears or tissue prints were incubated in Accustain Wright stain for 15 s, washed for 1 minute in distilled water, incubated in Accustain Giemsa for 1.5 min, and washed for 3 min in distilled water according to manufacturer's protocol (Sigma Diagnostics) .
Microscopy
All slides were examined using a Nikon E800 differential-interference contrast microscope equipped with 10X, 20X, and 40X dry objectives and with 60X and 100X oil objectives. Micrographs were recorded at various magnifications using a Digital SPOT32 camera (Diagnostic Instruments, Inc) . Images were prepared using Adobe Photoshop 4.0 or 5.0.
Library Screening
A N. coriiceps spleen cDNA library in lambda gtlO was screened to obtain full-length clones corresponding to the RDA products. Bacteriophage were plated on C600Hfi at 20,000 pfu/100 mm NZY plate, and the plates were incubated overnight at 37°C. Replicas containing plaque DNA were prepared on nylon filters (Osmonics, Inc.) by conventional methods (16). Filter-bound phage DNA was denatured in 1.5 M NaCl, 0.5 M NaOH for 2 min, renatured in 1.5 M NaCl, 0.5 M Tris-HCl (pH 8.0) for 5 min, and washed for 30 s in 2X SSC. DNA was fixed to the filters by UV photocross-linking for 45 s using a Spectra-Linker (Fisher) . Filters were prehybridized in 6X SSC, 0.5% SDS, 50 μg/ml heparin, 0.1% sodium diphosphate for at least 1 h at 60°C. After removal of the prehybridization solution, radiolabeled probes, prepared from RDA clones as before (see Northern Slot Blots) , were added, and the filters were incubated at 60°C overnight with agitation. Filters were washed with 3X SSC, 0.5% SDS, 1 mM EDTA at 60°C at least 2 times for 15 min/wash and then exposed to X-Ray film (Fuji Film). Positive plaques chosen for secondary screening were picked and eluted into SM buffer. All phage isolates were purified to the tertiary level. Clone DNA was prepared from miniprep cultures using the Qiagen Lambda Mini Kit. Phage DNA inserts were sequenced by automated DNA sequencing on an ABI Model 370 Sequencer (University of Maine DNA Sequencing Facility) .
Genomic Southern Blots Genomic DNA of high molecular weight was isolated from testes tissues of N. coriiceps or C. aceratus, or from whole zebrafish, by the proteinase K protocol (16) and stored in distilled H20 or TE (pH 8.0). Aliquots of DNA
(10 μg) were digested separately by addition of 40 U of Pstl, HindiII, BamHI or EcoRI (New England Biolabs) at 37°C for at least 3 h, and the digests were electrophoresed on 0.8% agarose gels (Fisher) in IX TBE overnight at 30 Volts. DNA fragments were denatured in the gels by soaking in 1.5 M NaCl, 0.5 N NaOH twice for 30 min each, then renatured twice in 1.5 M NaCl, 0.5 M Tris-HCl (pH 8.0) (30 min per treatment) . The gels were rinsed briefly in 6X SSC, and the DNA fragments were transferred to Hybond XL nylon membrane by capillary blotting overnight in 6X SSC. DNA was fixed to the membranes by UV photocross-linking for 45 s using a Spectra-Linker (Fisher) and stored in the dark until use.
To determine the status of known hematopoietic genes in the genomes of red- and white-blooded Antarctic fish, Southern blots of genomic DNAs were hybridized to cDNA probes from other vertebrates. Zebrafish hematopoietic gene probes were kindly provided by Dr. Leonard Zon (Children's Hospital and Harvard Medical School). These included cDNAs encoding α-spectrin and Band 3. The murine erythropoietin receptor (mEpoR) cDNA was a gift from Dr. Alan D' Andrea and Dr. Daniel Tenen. Following pre- hybridization, blots were hybridized to 32P-labeled probes overnight in IX PerfectHyb Plus (Sigma) at 60°C (zebrafish cDNAs, and murine EpoR) . Blots probed with zebrafish cDNAs were washed twice to moderate stringency (0.5X SSC, 0.1% SDS at hybridization temperature) followed by higher stringency washes (0.2X SSC, 0.1% SDS) if necessary. Blots probed with mEpoR cDNA were washed twice at moderate stringency (0.5X SSC, 0.1% SDS). Membranes were exposed to Kodak X-Ray film for 24-72 h. Membranes were stripped by incubation in 0.1% SDS, 0. IX SSC at 100°C for 10 min and reused a maximum of 3 times.
It is understood that one of ordinary . skill in the art will be able to effect minor variations to the embodiments of the methods herein described, without departing from the spirit and scope of the invention as set forth in the claims . References
1. Weissman, I.L. (2000) Cell 100, 157-168
2. Migliaccio, A.R., Vannucchi, A.M., and Migliaccio, G. (1996) Interna tional Journal of Hema tology 64, 1-
29
3. Mortiz, K.M., Lim, G.B., and Wintour, E.M. (1997)
American Journal of Physiology 273, R1829-R1844
4. Ward, A.C., Touw, I., and Yoshimura, A. (2000) Blood 95, 19-29
5. Orkin, S.H. and Zon, L.I. (1997) Annual Review of
Genetics 31, 33-60
6. Pandolfi, P.P. (1998) Seminars in Hema tology 35, 136-
148 7. Ransom, D.G., Haffter, P., Odenthal, J., Brownlie, A., Vogelsang, E., Kelsh, R.N., Brand, M., van Eeden, F.J.M., Furutani-Seiki, M., Granato, M., Hammerschmidt, M., Heisenberg, C.-P., Jiang, Y.- J., Kane, D.A., Mullins, M.C., and Nusslein- Volhard, C. (1997) Development 123, 311-319
8. di Prisco, G., D'Avino, R., Caruso, C, Tamburini, M.,
Camardella, L., Rutigliano, B., Carratore, V., and Romano, M. (1991) in Biology of Antarctic Fish (di Prisco, G., Maresca, B., and Tota, B., eds) pp. 263-281, Springer-Verlag, Berlin
9. Eastman, J.T. (1993) Antarctic Fish Biology: Evolution in a Unique Environment, Academic Press, San Diego 10. Macdonald, J.A., Montgomery, J.C., and Wells, R.M.G. (1987) Advances in Marine Biology 24, 321-388 11. Zhao, Y., Ratnayake-Lecamwasam, M., Parker, S.K., Cocca, E., Camardella, L., di Prisco, G., and Detrich, H.W.I. (1998) Journal of Biological Chemistry 24, 14745-14752 12. Lisitsyn, N., Lisitsyn, Ni., and Wigler, M. (1993)
Science 259, 946-951
13. Hubank, M. and Schatz, D.G. (1994) Nucleic Acids
Research 22, 5640-5648 14. Cocca, E., Ratnayake-Lecamwasam, M., Parker, S.K.,
Camardella, L., Ciaramella, M., di Prisco, G., and Detrich, H.W.III. (1995) Proceedings from the Na tional Academy of Sciences 92, 1817-1821 15. Klickstein, L.B., Neve, R.L., Golemis, E.A., and Gyuris, J. (1995) in Current Protocols in
Molecular Biology (Ausubel, F.M., Brent, R. , Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K., eds) pp. 2-14, John Wiley & Sons . 16. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecular Cloning: A Labora tory Manual, Cold Spring Harbor Laboratory Press, Plainview, NY
17. Altschul, S.F., Madden, T.L., Schaffer, A.A., Zhang,
J., Zhang, Z., Miller, W., and Lipman, D.J. (1997) Nucleic Acids Research 25, 3389-3402
18. Salas, F., Haas, J., Brunk, B., Stoeckert, C.J.J., and
Overton, G.C. (1998) Nucleic Acids Research 26, 288-289
19. Grϋnewald-Jahno, S., Keesey, J., Leous, M., van Miltenburg, R., and Schroeder, C. (1996) in
Nonradioactive In Situ Hybridiza tion Applica tion Manual (Grunewald-Jahno, S., Keesey, J. , Leous, M., van Miltenburg, R., and Schroeder, C, eds) pp. 44-45, Boehringer Mannheim GmbH, Biochemica, Mannheim 20. Dijkman, H.B.P.M., Mentzel, S., de Jong, A.S., and
Assmann, K.J.M. (1996) in Nonradioactive In Situ Hybridization Application Manual (Grϋnewald-Jahno, S., Keesey, J., Leous, M. , van Miltenburg, R., and Schroeder, C, eds) pp. 152-156, Boehringer
Mannheim GmbH, Biochemica, Mannheim
21. Ye, T.-Z., Gordon, C.T., Lai, Y.-H., Fujiwara, Y.,
Peters, L.L., Perkins, A.C., and Chui, D.H.K. (2000) Gene 242, 337-345 22. Uochi, T. and Asashima, M. (1998) Gene 211, 245-250

Claims

CLAIMS 1. A method of screening a red-blooded fish for erythropoesis-related genes, comprising using a subtractive hybridization technique to eliminate from analysis, cDNA clones derived from a hematopoietic organ of a red-blooded fish which hybridize with cDNA clones derived from a hematopoietic organ of a white-blooded fish of the suborder Notothenioidei.
2. The method of claim 1, wherein the hybridization technique is polymerase chain reaction (PCR) -based representational differential analysis.
3. A method of screening a red-blooded fish for erythropoesis-related genes, comprising: providing a first library of double-stranded DNA fragments derived from a hematopoietic organ of the red- blooded fish; ligating adapter DNA molecules to ends of the DNA fragments of the first library, the adapters having been designed to allow, during a polymerase chain reaction amplification protocol, exponential amplification of double-stranded DNA fragments having the adapters; providing a second library of DNA fragments derived from a hematopoietic organ of a white-blooded fish lacking erythrocytes; mixing the first library of adapter-ligated DNA fragments with the second library of DNA fragments to form a first DNA mixture; subjecting the first DNA mixture first to conditions conducive to substantially complete melting of double- stranded DNA fragments of the mixture into single-strand DNA fragments, and then to conditions conducive to annealing of the melted single-strand DNA fragments into double-stranded DNA molecules, to produce a second DNA mixture; subjecting the second DNA mixture to multiple rounds of polymerase chain reaction-based amplification, to produce a third DNA mixture; subjecting the third DNA mixture to conditions conducive to digestion of single-strand DNA, to produce a fourth mixture that is enriched for DNA sequences unique to the hematopoietic organ of the red-blooded fish; subjecting the fourth mixture to multiple rounds of polymerase chain reaction-based amplification, to produce a fifth DNA mixture; subjecting the fifth mixture to restriction endonuclease digestion; and inserting each restriction-endonuclease-digested fragment from the fifth DNA mixture into a plasmid vector, thereby producing multiple clones of DNA sequences from the hematopoietic organ of the red-blooded fish.
4. The method of claim 1 or 3, wherein the red-blooded fish is of the suborder Notothenioidei .
5. The method of claim 1 or 3, wherein the red-blooded fish is Notothenia coriiceps.
6. The method of claim 1 or 3, wherein the white-blooded fish is an icefish of the family Channichthyidae.
7. The method of claim 1 or 3, wherein the white-blooded fish is Chaenocephalus aceratus .
8. The method of claim 4, wherein the white-blooded fish is an Antarctic icefish and the red-blooded fish is an Antarctic fish.
9. The method of claim 1 or 3, further comprising isolating a DNA clone derived from the red-blooded fish after subtraction of red-blooded fish DNA fragments that hybridize to DNA fragments derived from the white-blooded fish head kidney.
10. The method of claim 9, further comprising determining whether the isolated DNA clone expresses a novel gene involved in erythropoiesis.
11. The method of claim 10, further comprising determining a sequence of the isolated DNA clone.
12. The method of claim 10, further comprising isolating a protein encoded by the isolated clone.
13. The method of claim 3, wherein the adapters each have an identifiable tag.
14. The method of claim 1 or 3, wherein the hematopoietic organ is the head kidney.
15. A cold-inducible RNA-binding protein (CIRP) -encoding gene comprising the sequence of SEQ ID. NO: 1.
16. A cold-inducible RNA-binding protein (CIRP) -encoding gene consisting essentially of the sequence of SEQ ID. NO: 1.
17. A nucleic acid probe consisting essentially of the sequence of SEQ ID NO: 1.
18. An isolated and purified polynucleotide consisting of the sequence of SEQ ID NO: 1.
19. A protein encoded by a gene consisting essentially of the sequence of SEQ ID. NO: 1.
20. A G protein-binding factor-coding gene comprising the sequence of SEQ ID NO: 3.
21. A G protein-binding factor-coding gene consisting essentially of the sequence of SEQ ID NO: 3.
22. An isolated and purified polynucleotide consisting of the sequence of SEQ ID NO: 3.
23. A nucleic acid probe consisting essentially of SEQ ID NO: 3.
24. A protein encoded by a gene consisting essentially of the sequence of SEQ ID. NO: 3.
PCT/US2000/020746 1999-07-29 2000-07-31 Isolation of novel hemapoietic genes by representational difference analysis WO2001009387A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14620199P 1999-07-29 1999-07-29
US60/146,201 1999-07-29

Publications (1)

Publication Number Publication Date
WO2001009387A1 true WO2001009387A1 (en) 2001-02-08

Family

ID=22516262

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/020746 WO2001009387A1 (en) 1999-07-29 2000-07-31 Isolation of novel hemapoietic genes by representational difference analysis

Country Status (1)

Country Link
WO (1) WO2001009387A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458465A (en) * 2009-04-13 2012-05-16 范因斯坦医学研究院 Treatment of inflammatory diseases by inhibiting cold- inducible rna-binding protein (cirp)
US9957295B2 (en) 2013-09-24 2018-05-01 The Feinstein Institute For Medical Research Peptides inhibiting cold-inducible RNA binding protein activity

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500356A (en) * 1993-08-10 1996-03-19 Life Technologies, Inc. Method of nucleic acid sequence selection
WO1997007244A1 (en) * 1995-08-11 1997-02-27 The United States Of America, Represented By The ISOLATION OF AMPLIFIED GENES VIA cDNA SUBTRACTIVE HYBRIDIZATION
US5643761A (en) * 1993-10-27 1997-07-01 The Trustees Of Columbia University In The City Of New York Method for generating a subtracted cDNA library and uses of the generated library
US5712127A (en) * 1996-04-29 1998-01-27 Genescape Inc. Subtractive amplification
US5804382A (en) * 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences
US5837524A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polynucleotide products
US5837468A (en) * 1995-06-07 1998-11-17 Pioneer Hi-Bred International, Inc. PCR-based cDNA substractive cloning method
US5837815A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polypeptide products
US5876932A (en) * 1995-05-19 1999-03-02 Max-Planc-Gesellschaft Zur Forderung Der Wissenschaften E V. Berlin Method for gene expression analysis

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500356A (en) * 1993-08-10 1996-03-19 Life Technologies, Inc. Method of nucleic acid sequence selection
US5643761A (en) * 1993-10-27 1997-07-01 The Trustees Of Columbia University In The City Of New York Method for generating a subtracted cDNA library and uses of the generated library
US5837524A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polynucleotide products
US5837815A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polypeptide products
US5876932A (en) * 1995-05-19 1999-03-02 Max-Planc-Gesellschaft Zur Forderung Der Wissenschaften E V. Berlin Method for gene expression analysis
US5837468A (en) * 1995-06-07 1998-11-17 Pioneer Hi-Bred International, Inc. PCR-based cDNA substractive cloning method
WO1997007244A1 (en) * 1995-08-11 1997-02-27 The United States Of America, Represented By The ISOLATION OF AMPLIFIED GENES VIA cDNA SUBTRACTIVE HYBRIDIZATION
US5712127A (en) * 1996-04-29 1998-01-27 Genescape Inc. Subtractive amplification
US5804382A (en) * 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
COCCA E. ET AL.: "Genomic remments of alpha-globin genes in the hemoglobinless antarctic icefishes", PROC. NATL. ACAD. SCI., USA, vol. 92, March 1995 (1995-03-01), pages 1817 - 1821, XP002931540 *
SIDELL B.D. ET AL.: "Variable expression of myoglobin among the hemoglobinless antarctic icefishes", PROC. NATL. ACAD. SCI., USA, vol. 94, April 1997 (1997-04-01), pages 3420 - 3424, XP002931539 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458465A (en) * 2009-04-13 2012-05-16 范因斯坦医学研究院 Treatment of inflammatory diseases by inhibiting cold- inducible rna-binding protein (cirp)
US8703138B2 (en) 2009-04-13 2014-04-22 The Feinstein Institute For Medical Research Treatment of inflammatory diseases by inhibiting cold-inducible RNA-binding protein (CIRP)
US9109023B2 (en) 2009-04-13 2015-08-18 The Feinstein Institute For Medical Research Treatment of inflammatory diseases by inhibiting cold-inducible RNA-binding protein (CIRP)
CN102458465B (en) * 2009-04-13 2015-09-02 范因斯坦医学研究院 Inflammatory diseases is treated by suppressing cold induction rna binding protein (CIRP)
US9957295B2 (en) 2013-09-24 2018-05-01 The Feinstein Institute For Medical Research Peptides inhibiting cold-inducible RNA binding protein activity

Similar Documents

Publication Publication Date Title
CA2239896C (en) Method for evaluation of polymorphic genetic sequences, and the use thereof in identification of hla types
EP0607151B1 (en) A method of detecting and discriminating between nucleic acid sequences
Uhrig et al. Multiplex-FISH for pre-and postnatal diagnostic applications
CN103781918B (en) The method and product detected for the part of tissue samples amplifying nucleic acid or space
US7799528B2 (en) Therapeutic and diagnostic applications of genes differentially expressed in lympho-hematopoietic stem cells
US5424184A (en) DNA sequence-based HLA class I typing method
JP2001521754A (en) Probe array for DNA identification and method of using probe array
JP2002531056A (en) Gel microdrop in gene analysis
KR20220156837A (en) Spatially resolved single cell RNA sequencing method
Van der Ploeg Cytochemical nucleic acid research during the twentieth century
Angerer et al. Delayed accumulation of maternal histone mRNA during sea urchin oogenesis
WO2001009387A1 (en) Isolation of novel hemapoietic genes by representational difference analysis
La Starza et al. Complex variant Philadelphia translocations involving the short arm of chromosome 6 in chronic myeloid leukemia
Yamaza et al. Detection of differentially expressed genes in the early developmental stage of the mouse mandible
Schreuder et al. Mutual exclusion of t (11; 18)(q21; q21) and numerical chromosomal aberrations in the development of different types of primary gastric lymphomas
CN111433359A (en) Method for preparing cDNA library
Detrich III et al. Comparative genomics in erythropoietic gene discovery: synergisms between the Antarctic icefishes and the zebrafish
JP5301281B2 (en) Organ-specific gene, identification method thereof and use thereof
Goldschmidt et al. Interstitial insertion of RARα gene into PML gene in a patient with acute promyelocytic leukemia (APL) lacking the classic t (15; 17)
Vicari et al. Microdissection and chromosome painting
KR101928887B1 (en) Single nucleotide polymorphism markers for determining Jeju black cattle and the uses thereof
EP0625573B1 (en) Novel dna, polypeptide coded for thereby, and method of detecting both
CN111118131B (en) Sex identification marker for portunus trituberculatus
JP2004089057A (en) Method for judging rh negative
EP2427776A1 (en) Method for the determination of p blood groups

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP